EMA Submission Planned in the Coming Weeks WESTON, Mass.--(Healthcare Sales & Marketing Network)--Today Biogen Idec (BIIB) announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of PL...
Biopharmaceuticals, Neurology
Biogen Idec, PLEGRIDY, peginterferon beta-1a, multiple sclerosis

Available Live 3D TEE and new breakthrough ICE catheter to reduce need for two separate cardiac ultrasound systems ANDOVER, Mass., May 21, 2013 -- (Healthcare Sales & Marketing Network) -- Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announce...
Devices, Cardiology
Royal Philips Electronics, St. Jude Medical, CX50 xMATRIX, ultrasound

One of the First Healthcare Providers to Install Toshiba’s Aquilion ONE ViSION Edition TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--West Virginia University Hospitals (WVUH) wanted to acquire new technology to improve workflow and patient car...
Devices, Radiology
Toshiba America Medical Systems, Aquilion, ONE ViSION Edition, CT

Will Fund Development of Lead Compound KPT-330 Through Pivotal Studies in Two Oncology Indications NATICK, Mass., May 20, 2013 -- (Healthcare Sales & Marketing Network) -- Karyopharm Therapeutics Inc., a leader in the new field of nuclear transport modu...
Biopharmaceuticals, Oncology, Venture Capital, Personnel
Karyopharm Therapeutics

WOBURN, Mass., May 20, 2013 -- (Healthcare Sales & Marketing Network) -- Flexion Therapeutics, Inc. today announced the addition of Frederick W. Driscoll to its management team as chief financial officer. Mr. Driscoll has more than 30 years of financial m...
Biopharmaceuticals, Personnel
Flexion Therapeutics

ALISO VIEJO, Calif., May 20, 2013 -- (Healthcare Sales & Marketing Network) -- Sequent Medical, Inc. announced today that it has received CE mark for the SL ("Single Layer") family of WEB® Aneurysm Embolization Devices, and has commenced a c...
Devices, Interventional, Radiology, Product Launch
Sequent Medical, Aneurysm, Embolization, MicroBraid, WEB SL, WEB SLS

Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(Healthcare Sales & Marketing Network)--Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and...
Devices, Monitoring, FDA
Covidien, Nellcor, pulse oximetry

Dr. Giora Yaron, joint Chairman at Itamar: "Itamar Medical is at a pivotal point of transitioning into an accelerated commercial phase. Gilad is well positioned to lead the company towards realizing our ambitious growth projections." CAESAREA,...
Devices, Personnel
Itamar Medical, WatchPAT, sleep apnea, obstructive sleep apnea

ompany to Focus on Small Molecule Selective Translation Regulators for Cancer SAN DIEGO, May 20, 2013 -- (Healthcare Sales & Marketing Network) -- eFFECTOR Therapeutics, a newly established biopharmaceutical company, today announced the completion of a...
Biopharmaceuticals, Venture Capital, Personnel
eFFECTOR Therapeutics

Results of Randomized JACK-EPC Trial Published in Minerva Cardioangiologica HONG KONG, May 20, 2013 -- (Healthcare Sales & Marketing Network) -- OrbusNeich today announced that the company's Genous Stent is associated with a significantly lower rate of...
Devices, Interventional Cardiology
OrbusNeich, Genous Stent, JACK-EPC, binary restenosis

Proposed Transactions offer shareholders highly unique investment and asset proposition Acquisition of AOP Orphan – a private, orphan disease company headquartered in Vienna, Austria Acquires 48% of Newbridge Pharmaceuticals – a private Africa, Middl...
Biopharmaceuticals, Mergers & Acquisitions
Elan Corp, AOP Orphan Pharmaceuticals, Newbridge Pharmaceuticals, Speranza

The Montage 2 Dual Filter System is the only approved device to protect the carotid arteries by capturing embolic debris during TAVR. SANTA ROSA, Calif., May 20, 2013 -- (Healthcare Sales & Marketing Network) -- Claret Medical, Inc. announced the publi...
Devices, Interventional Cardiology
Claret Medical, TAVR , Montage Dual Filter, Embolic Protection

Linear accelerator is island's first Versa HD PONCE, Puerto Rico, May 17, 2013 -- (Healthcare Sales & Marketing Network) -- Serving a region of 650,000 inhabitants in southern, central and western Puerto Rico, Caribbean Imaging and Radiation Therapy (C...
Devices, Oncology
Elekta, Versa HD, stereotactic, radiosurgery, radiotherapy

PLEASANTON, Calif., May 17, 2013 -- (Healthcare Sales & Marketing Network) -- Thoratec Corporation (THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it has rec...
Devices, Cardiology, FDA
Thoratec, HeartMate II, Pocket Controller, HeartMate II LVAD

Genentech and Biogen Idec have filed for re-hearing in the United States COPENHAGEN, Denmark, May 17, 2013 -- (Healthcare Sales & Marketing Network) -- Genmab A/S (GEN.CO) announced today that Genentech and Biogen Idec have filed for a re-hearing en ba...
Biopharmaceuticals, Litigation
Genmab, Genentech, Biogen Idec, GlaxoSmithKline, Arzerra

NATICK, Mass., May 17, 2013 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) is scheduled to participate at the annual EuroPCR Scientific Program May 21-24 in Paris. "We are pleased to present a particularly rich an...
Devices, Interventional Cardiology
Boston Scientific, NG PROMUS trial, Promus PREMIER, SYNERGY Stent

Data Showed Reduced Nocturnal Systolic Blood Pressure Elevations and Periodic Limb Movements During Sleep in Restless Legs Syndrome (RLS) Patients First study of its kind will be presented at the Annual Scientific Meeting of the American Society of Hype...
Biopharmaceuticals
UCB , Neupro, Rotigotine, Restless Legs Syndrome

More than 18 Million Brazilians have Reimbursable Access to MGuard EPS BOSTON and TEL AVIV, Israel, May 16, 2013 -- (Healthcare Sales & Marketing Network) --InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader i...
Devices, Interventional, Cardiology, Reimbursement
InspireMD, MGuard, Embolic Protection, Coronary Stent

To Begin I-124-CLR1404 (LIGHT) Phase 2 Imaging Trial in Brain Cancer in Early 2014 Evaluating I-131-CLR1404 (HOT) Potential Phase 2 Indications and Trial Designs To File CLR1502 (GLOW2) IND for Intraoperative Tumor Margin Illumination by End 2013 MADI...
Biopharmaceuticals
Novelos Therapeutics, I-124-CLR1404, I-131-CLR1404, radiotherapeutic

Up To 30 European Sites To Join 46 Active Sites In The US BETHESDA, Md., May 16, 2013 -- (Healthcare Sales & Marketing Network) -- Northwest Biotherapeutics (NWBO) (NW Bio), a biotechnology company developing DCVax®-L personalized immune therapies ...
Biopharmaceuticals, Oncology
Northwest Biotherapeutics, DCVax-L, personalized immune therapies, Glioblastoma